Post-IPO Equity - Acer Therapeutics - Sep 19, 2017 Funding Round Profile - Cointime

Bitcoin $86,981.53 -1.67%
Ethereum $3,158.93 -5.06%
BNB $606.13 -6.73%
Optimism $1.54 -13.43%
Arbitrum $0.59 -10.92%
Solana $206.92 -4.78%
Polygon $0.37 -10.80%
Cosmos $4.97 -9.06%
Avalanche $32.05 -9.40%

Bitcoin $86,981.53 -1.67%
Ethereum $3,158.93 -5.06%
BNB $606.13 -6.73%
Optimism $1.54 -13.43%
Arbitrum $0.59 -10.92%
Solana $206.92 -4.78%
Polygon $0.37 -10.80%
Cosmos $4.97 -9.06%
Avalanche $32.05 -9.40%

Acer Therapeutics

company

Funding Round

Post-IPO Equity

Money Raised

$ 15.70M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
TVM Capital Life Science	-	Yes	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
May 6, 2016	Post-IPO Equity	$ 8.14M	TVM Capital Life Science	Detail
Apr 2, 2015	Post-IPO Debt	$ 2.10M		Detail